Prot #67896062PAH4005: An International, Non-drug Interventional, Real-world Cohort of PAH Patients Newly Initiating PAH Therapy with Guideline Directed Assessments of Disease Severity: CARE PAH (Contemporary Real-World PAH Best Practice)

Project: Research project

Project Details

StatusActive
Effective start/end date1/14/224/30/27

Funding

  • Parexel (Prot #67896062PAH4005 // Prot #67896062PAH4005)
  • Actelion Pharmaceuticals Ltd. (Prot #67896062PAH4005 // Prot #67896062PAH4005)